Radiation therapy vendor Varian Medical Systems posted mixed results for the company's fiscal third quarter, with revenue increases overall but dips in its Oncology Systems and Imaging Components businesses.
For the quarter, Varian reported revenues of $784 million, up 5% from $747.7 million in the same period last year. Net income was $113.6 million, compared with $107.1 million in the corresponding quarter of 2014.
The company saw a 3% decrease in sales in its Oncology Systems division, from $578 million in 2014 to $559 million for this year's period. Also, revenue in its Imaging Components business decreased by 17%, from $162 million to $135 million, which Varian attributed to a slowdown in the global market for security and inspection products.
In other company news, Varian announced that it plans to acquire Claymount, a privately held Dutch x-ray components supplier, for 50 million euros ($54.5 million). The deal is expected to close in early August.
